IL6 and metabolic disease: GrimAge residuals showed associations with a broad range of blood-based biomarkers implicated in age-related disease and premature mortality risk, including inflammation (CRP, WBC, IL-6, and TNF-α), oxidative stress (GGT), neuropathology (GFAP), and metabolic disease (MetS).